Immunotherapy Today

Immunotherapy News From Around The World

Aimmune Therapeutics (AIMT) Announces Data on Terminology Used with Oral Immunotherapy Were Presented at …

Posted by btwatson on May 29, 2018 1:20 pm
Tags:
Categories: Crispr Articles

Source: Aimmune Therapeutics (AIMT) Announces Data on Terminology Used with Oral Immunotherapy Were Presented at …

[unable to retrieve full-text content]

  1. Aimmune Therapeutics (AIMT) Announces Data on Terminology Used with Oral Immunotherapy Were Presented at …  StreetInsider.com
  2. Allergy Therapeutics plc – Positive new data with house-dust mite immunotherapy  Nasdaq
  3. Allergy Therapeutics announces positive new clinic data with house-dust mite immunotherapy  Proactive Investors UK
  4. Full coverage

Published at Tue, 29 May 2018 12:12:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • Immunotherapy Advances in SCLC Highlight Promise, Limitations, and Biomarker Needs - OncLive
    November 15, 2025
  • Dr Bhora on How Perioperative Immunotherapy Is Reshaping the Treatment Paradigm in Resectable NSCLC - OncLive
    November 15, 2025
  • C. Ola Landgren: Successful Myeloma Immunotherapy Preceptorship at Sylvester Myeloma Institute - Oncodaily
    November 15, 2025
  • Biomimetic mRNA Delivery System Enhances Targeted Immunotherapy for Colorectal Cancer - BIOENGINEER.ORG
    November 15, 2025
  • TKIs Take Lead After Immunotherapy in Metastatic Kidney Cancer - Cure Today
    November 14, 2025
  • Why Cancer Care Needs a "Both/And" Approach - Targeted Oncology
    November 14, 2025
  • Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations - Oncodaily
    November 14, 2025
  • Gertjan Rasschaert: The Dawn of Immunotherapy in Mismatch Repair Proficient Colorectal Cancer - Oncodaily
    November 14, 2025
  • Comprehensive analysis of ALYREF gene expression and its correlation with immunotherapy efficacy and circulating tumor cells in bladder cancer - Nature
    November 14, 2025
  • The latest chemo-immunotherapy model for heterogeneous tumors - EurekAlert!
    November 14, 2025

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com